Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of QS-M Needle -Free Injector Versus Needle-insulin Pen as a Drug Carrier for Controlling the Blood Glucose in T2DM：a Randomized, Parallel Controlled, Open-label, Multicenter Trial

NCT03243903 is registered in ClinicalTrials.gov with Beijing QS Medical Technology Co., Ltd. as lead sponsor.

NCT NCT03243903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03243903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of QS-M Needle -Free Injector Versus Needle-insulin Pen as a Drug Carrier for Controlling the Blood Glucose in T2DM：a Randomized, Parallel Controlled, Open-label, Multicenter Trial
Lead sponsor
Beijing QS Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
August 18, 2017
Completion date
November 8, 2018
Enrollment
427 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes